Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 24;107(5):1131–1143. doi: 10.3324/haematol.2020.267096

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© 2022 Ferrata Storti Foundation

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

PMC Copyright notice

Figure 2. — GECPAR specific expression in germinal center B cell-like cells and correlation with essential genes. (A) Top: GECPAR expression in a panel of 22 diffuse large B-cell lymphoma (DLBCL) cell lines, 16 germinal center B cell-like (GCB) and 8 activated B cell-like, bottom, expression level of GECPAR antisense transcript, measured as control. (B) Top: box plots of GECPAR expression quantified by total RNA sequencing in normal individuals or GCB- or ABC-DLBCL patients. Bottom: box plots of GECPAR expression in normal individuals stratified for cell of origin. (C) Heat map of differential gene expression, in GCB-DLBCL cell lines dichotomized for GECPAR expression. (D) Preranked gene set enrichment analysis, in GCB-DLBCL cell lines classified for GECPAR expression. (E) Heat map of differential gene expression, in 16 GCB-DLBCL patients, classified for GECPAR expression. (F) Preranked gene set enrichment analysis, in DLBCL patients classified for GECPAR expression